Suppression of Murine Chronic Relapsing Experimental Autoimmune Encephalomyelitis by the Oral Administration of Myelin Basic Protein

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4230-4238

  Meyer, Abbie L ^a   Benson, Jacqueline M ^a   Gienapp, Ingrid E ^a   Cox, Karen L ^a   Whitacre, Caroline C ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC DISEASE; DESENSITIZATION; FEMALE; GUINEA PIG; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; MOUSE; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; SECRETION;

ADMINISTRATION, ORAL; ANIMALS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GUINEA PIGS; IMMUNE TOLERANCE; MALE; MICE; MYELIN BASIC PROTEINS; RECURRENCE;

EID: 0030293682     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Olitsky, P. K., and R. H. Yager. 1949. Experimental disseminated encephalomyelitis in white mice. J. Exp. Med. 90:213.
2. Brown, A. M., and D. E. McFarlin. 1981. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab. Invest 45:278.
3. Lublin, F. D., P. H. Maurer, R. G. Berry, and D. Tippet. 1981. Delayed, relapsing experimental allergic encephalomyelitis in mice. J. Immunol. 126:819.
4. Fritz, R. B., C.-H. J. Chou, and D. E. McFarlin. 1983. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J. Immunol. 130:1024.
5. Mokhtarian, F., D. E. McFarlin, and C. S. Raine. 1984. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309:356.
6. Fritz, R. B., M. J. Skeen, C.-H. J. Chou, M. Garcia, and I. K. Egorov. 1985. Major histocompalibility complex-linked control of the murine immune response to myelin basic protein. J. Immunol. 134:2328.
7. Lublin, F. D. 1985. Relapsing experimental allergic encephalomyelitis: an autoimmune model of multiple sclerosis. Springer Semin. Immunopathol. 8:197.
8. 1 mice: Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein. J. Immunol. 141:1143.
9. Traugott, U. 1990. Evidence for immunopathogenesis. In Handbook of Multiple Sclerosis, Vol. 8. S. D. Cook, ed. Marcel Dekker, New York, p. 101.
10. Khoury, S. J., H. L. Weiner, and D. A. Hafler. 1990. Immunologic basis of multiple sclerosis. In Handbook of Multiple Sclerosis, Vol. 8. S. D. Cook, ed. Marcel Dekker, New York, p. 129.
11. Miller, H., D. J. Newell, and A. Ridley. 1961. Multiple sclerosis: treatment of acute exacerbations with coritcotrophin (ACTH). Lancet 2:1120.
12. Rose, A. S., J. W. Kuzma, and J. F. Kurtzke. 1970. Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo: final report. Neurology 20:1.
13. Arnason, B. G. 1993. Interferon beta in multiple sclerosis. Neurology 43:641.
14. Group, T. I. M. S. S. 1993. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: clinical results of a multicenter randomized, double-blind, placebo-controlled trial. Neurology 43:655.
15. Bitar, D. M., and C. C. Whitacre. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112:364.
16. Higgins, P. J., and H. L. Weiner. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140:440.
17. Whitacre, C. C., I. E. Gienapp, C. G. Orosz, and D. M. Bitar. 1991. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 147:2155.
18. Miller, A., O. Lider, A. Al-Sabbagh, and H. L. Weiner. 1992. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species. J. Neuroimmunol. 39:243.
19. Miller, A., O. Lider, A. B. Roberts, M. B. Sporn, and H. L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89:421.
20. Miller, A., A. Al-Sabbagh, L. M. B. Santos, M. P. Das, and H. L. Weiner. 1993. Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J. Immunol. 151:7307.
21. Javed, N. H., I. E. Gienapp, K. L. Cox, and C. C. Whitacre. 1995. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 155:1599.
22. Weiner, H. L., G. A. Mackin, M. Matsui, E. J. Orav, S. J. Khoury, D. M. Dawson, and D. A. Hafler. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259:1321.
23. Brod, S. A., A. Al-Sabbagh, R. A. Sobel, D. A. Hafler, and H. L. Weiner. 1991. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens. IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann. Neurol. 29:615.
24. Friedman, A., and H. L. Weiner. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. J. Immunol. 91:6688.
25. Whitacre, C. C., I. E. Gienapp, A. Meyer, K. L. Cox, and N. Javed. 1996. Oral tolerance in experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 778:217.
26. Diebler, G. E., R. E. Martensen, and M. W. Kies. 1972. Large-scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:139.
27. Swanborg, R. H., J. E. Swierkosz, and R. G. Saieg. 1974. Studies on the species variability of experimental allergic encephalomyelitis in guinea pigs and rats. J. Immunol. 112:594.
28. Saffron, M., R. Franco-Saenz, A. Kong, D. Pepthadjopoulos, and F. Szoka. 1979. A model for the study of oral administration of peptide hormones. Can. J. Biochem. 57:548.
29. Hanson, D. G., M. J. Roy, S. D. Miller, E. G. Seidman, M. J. Thomas, I. R. Sanderson, J. N. Udall, I. Ely, and G. M. Green. 1993. Endopeptidase inhibition and intestinal antigen processing in mice. Reg. Immunol. 5:85.
30. Hanson, D. G., M. J. Roy, G. M. Green, and S. D. Miller. 1993. Inhibition of orally-induced immune tolerance in mice by prefeeding an endopeptidase inhibitor. Reg. Immunol. 5:76.
31. Matsuda, H., Y. Ikeda, and M. Kubo. 1992. Pharmacological study on Naja naja kaouthia. Lesson III. Effects of 50% ethanolic extracts from liver and gall bladder on phagocytic activity of mouse reticuloendothelial system. Yakugaku Zasshi J. Pharmaceut. Soc. Jpn. 112:183.
32. McCarron, R. M., R. J. Fallis, and D. E. McFarlin. 1990. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 29:73.
33. Perry, L. L., E. Barzaga-Gilbert, and J. Trotter. 1991. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 33:7.
34. Lehmann, P. V., T. Forsthuber, A. Miller, and E. E. Sercarz. 1992. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155.
35. Lehmann, P. V., E. E. Sercarz, T. Forsthuber, C. M. Dayan, and G. Gammon. 1993. Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol. Today 14:203.
36. Cross, A. H., V. K. Tuohy, and C. S. Raine. 1993. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:261.
37. McRae, B. L., C. L. Vanderlugt, M. C. DalCanto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75.
38. Tan, L.-J., M. Kennedy, M. C. DalCanto, and S. D. Miller. 1991. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen specific tolerance. J. Immunol. 147:1797.
39. Tan, L.-J., M. K. Kennedy, and S. D. Miller. 1992. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. J. Immunol. 148:2748.
40. Samson, M. F., and D. E. Smilek. 1995. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes. J. Immunol. 155:2737.
41. Gaur, A., B. Wiers, A. Liu, J. Rothbard, and C. G. Fathman. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258:1491.
42. O'Neill, J. K., D. Baker, and J. L. Turk. 1992 Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. J. Neuroimmunol. 41:177.
43. Chen, Y., V. K. Kuchroo, J.-I. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
44. Chen, Y., J.-I. Inobe, R. Marks, P. Gonnella, V. K. Kuchroo, and H. L. Weiner. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
45. Santambrogio, L., G. M. Hochwald, B. Saxena, C.-H. Leu, J. E. Martz, J. A. Carlino, N. H. Ruddle, M. A. Palladino, L. I. Gold, and G. J. Thorbecke. 1993. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis: antagonism between TGF-β and TNF. J. Immunol. 151:1116.
46. Santambrogio, L., G. M. Crisi, J. Leu, G. M. Hochwald, T. Ryan, and G. J. Thorbecke. 1995. Tolerogenic forms of autoantigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis. J. Neuroimmunol. 58:211.